Evidence map›Paper›PMID 25869783›Full record

ArticleJournal of Alzheimer's disease : JAD2015

Predicting Alzheimer's Disease Using Combined Imaging-Whole Genome SNP Data.

Dehan Kong, Kelly S Giovanello, Yalin Wang, Weili Lin, Eunjee Lee, Yong Fan, P Murali Doraiswamy, Hongtu Zhu

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Gene-Environment Analyses in a UK Biobank Skin Cancer Cohort Identifies Important SNPs in DNA Repair Genes That May Help Prognosticate Disease Risk.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. [Progress in the study of the imaging genomics of Alzheimer's disease].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
  15. Article
  16. Article
  17. A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2018
    Observational
  18. Radiomic analysis in prediction of Human Papilloma Virus status.Clinical and translational radiation oncology · 2017
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dehan KongDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.
Kelly S GiovanelloDepartment of Psychology, University of North Carolina, Chapel Hill, NC, USA.
Yalin WangSchool of Computing, Informatics and Decision Systems Engineering, Arizona State University, Tempe, AZ, USA.
Weili LinBiomedical Research Imaging Center, University of North Carolina, Chapel Hill, NC, USA.
Eunjee LeeDepartment of Statistics, University of North Carolina, Chapel Hill, NC, USA.
Yong FanDepartment of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
P Murali DoraiswamyDepartments of Psychiatry and Duke Institute for Brain Sciences, Duke University, Durham, NC, USA.
Hongtu ZhuDepartment of Biostatistics, University of North Carolina, Chapel Hill, NC, USA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Statistical Methods for Cancer Clinical TrialsP01CA142538 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOSOROK, MICHAEL R · 2010 to 2019
$21.3M
Statistical Analysis of Biomedical Imaging Data in Curved SpaceR01MH086633 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IBRAHIM, JOSEPH G · 2010 to 2018
$2.9M
Biostatistics and Mental Health Neuroimaging and Genomics Training GrantT32MH106440 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GILMORE, JOHN HORACE, KOSOROK, MICHAEL R · 2015 to 2019
$970k
MRI Biomarker Discovery for Preclinical Alzheimers Disease with Geometry MethodsR21AG043760 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, YALIN · 2013 to 2014
$409k
Longitudinal Analysis of Biomedical Imaging DataR21AG033387 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ZHU, HONGTU · 2009 to 2010
$334k
NCATS NIH HHS 1UL1TR001111NCATS NIH HHS UL1 TR001111NCATS NIH HHS UL1 TR002489NCI NIH HHS P01 CA142538NCI NIH HHS P01CA142538-01NCRR NIH HHS UL1 RR025747NIA NIH HHS AG033387NIA NIH HHS R21 AG033387NIA NIH HHS R21 AG043760NIA NIH HHS U01 AG024904NIMH NIH HHS MH086633NIMH NIH HHS R01 MH086633NIMH NIH HHS T32 MH106440
6 · The paper itself

Abstract

The growing public threat of Alzheimer's disease (AD) has raised the urgency to discover and validate prognostic biomarkers in order to predicting time to onset of AD. It is anticipated that both whole genome single nucleotide polymorphism (SNP) data and high dimensional whole brain imaging data offer predictive values to identify subjects at risk for progressing to AD. The aim of this paper is to test whether both whole genome SNP data and whole brain imaging data offer predictive values to identify subjects at risk for progressing to AD. In 343 subjects with mild cognitive impairment (MCI) enrolled in the Alzheimer's Disease Neuroimaging Initiative (ADNI-1), we extracted high dimensional MR imaging (volumetric data on 93 brain regions plus a surface fluid registration based hippocampal subregion and surface data), and whole genome data (504,095 SNPs from GWAS), as well as routine neurocognitive and clinical data at baseline. MCI patients were then followed over 48 months, with 150 participants progressing to AD. Combining information from whole brain MR imaging and whole genome data was substantially superior to the standard model for predicting time to onset of AD in a 48-month national study of subjects at risk. Our findings demonstrate the promise of combined imaging-whole genome prognostic markers in people with mild memory impairment.

Indexed as

Magnetic Resonance ImagingAgedAged, 80 and overAlzheimer DiseaseApolipoprotein E4Cognitive DysfunctionFemaleGenetic Association StudiesGenomeHippocampusHumansMalePolymorphism, Single NucleotidePrincipal Component AnalysisPsychiatric Status Rating ScalesApolipoprotein E4Alzheimer’s diseasegeneticsmagnetic resonance imagingproportional hazards modelsrisk

Identifiers

PMID25869783
PMCPMC4583331

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.